Q4 & FY 25-26 Consolidated
General information about company | ||
| Scrip code* | 544320 | |
| NSE Symbol* | CARRARO | |
| MSEI Symbol* | NOTLISTED | |
| ISIN* | INE0V7W01012 | |
| Name of company | CARRARO INDIA LIMITED | |
| Type of company | Main Board | |
| Class of security | Equity | |
| Date of start of financial year | 01-04-2025 | |
| Date of end of financial year | 31-03-2026 | |
| Date of board meeting when results were approved | 26-05-2026 | |
| Date on which prior intimation of the meeting for considering financial results was informed to the exchange | 14-05-2026 | |
| Description of presentation currency | INR | |
| Level of rounding | Millions | |
| Reporting Type | Quarterly | |
| Reporting Quarter | Fourth quarter | |
| Nature of report standalone or consolidated | Consolidated | |
| Whether results are audited or unaudited for the quarter ended | Unaudited | |
| Whether results are audited or unaudited for the Year to date for current period ended/year ended | Audited | |
| Segment Reporting | Single segment | |
| Description of single segment | Manufacturing | |
| Start date and time of board meeting | 26-05-2026 14:30 | |
| End date and time of board meeting | 26-05-2026 16:30 | |
| Whether cash flow statement is applicable on company | Yes | |
| Type of cash flow statement | Cash Flow Indirect | |
| Declaration of unmodified opinion or statement on impact of audit qualification | Declaration of unmodified opinion | |
Financial Results � Ind-AS | ||||
| Particulars | 3 months/ 6 months ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | ||
| Date of start of reporting period | 01-01-2026 | 01-04-2025 | ||
| Date of end of reporting period | 31-03-2026 | 31-03-2026 | ||
| Whether results are audited or unaudited | Unaudited | Audited | ||
| Nature of report standalone or consolidated | Consolidated | Consolidated | ||
| Part I | Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column. | |||
| 1 | Income | |||
| Revenue from operations | 6067.24 | 22554.91 | ||
| Other income | 75.24 | 285.25 | ||
| Total income | 6142.48 | 22840.16 | ||
| 2 | Expenses | |||
| (a) | Cost of materials consumed | 4543.94 | 16524.07 | |
| (b) | Purchases of stock-in-trade | 0 | 0 | |
| (c) | Changes in inventories of finished goods, work-in-progress and stock-in-trade | -48.57 | 38.28 | |
| (d) | Employee benefit expense | 407.56 | 1666.4 | |
| (e) | Finance costs | 47.82 | 194.84 | |
| (f) | Depreciation, depletion and amortisation expense | 112.85 | 457 | |
| (g) | Other Expenses | |||
| 1 | Other expenses | 529.93 | 2136.79 | |
| Total other expenses | 529.93 | 2136.79 | ||
| Total expenses | 5593.53 | 21017.38 | ||
| 3 | Total profit before exceptional items and tax | 548.95 | 1822.78 | |
| 4 | Exceptional items | 0 | -95 | |
| 5 | Total profit before tax | 548.95 | 1727.78 | |
| 6 | Tax expense | |||
| 7 | Current tax | 143.72 | 445.09 | |
| 8 | Deferred tax | -11.68 | -23.14 | |
| 9 | Total tax expenses | 132.04 | 421.95 | |
| 10 | Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement | 0 | 0 | |
| 11 | Net Profit Loss for the period from continuing operations | 416.91 | 1305.83 | |
| 12 | Profit (loss) from discontinued operations before tax | 0 | 0 | |
| 13 | Tax expense of discontinued operations | 0 | 0 | |
| 14 | Net profit (loss) from discontinued operation after tax | 0 | 0 | |
| 15 | Share of profit (loss) of associates and joint ventures accounted for using equity method | 0 | 0 | |
| 16 | Total profit (loss) for period | 416.91 | 1305.83 | |
| 17 | Other comprehensive income net of taxes | 1.31 | 19.39 | |
| 18 | Total Comprehensive Income for the period | 418.22 | 1325.22 | |
| 19 | Total profit or loss, attributable to | |||
| Profit or loss, attributable to owners of parent | 416.84 | 1305.57 | ||
| Total profit or loss, attributable to non-controlling interests | 0.06 | 0.27 | ||
| 20 | Total Comprehensive income for the period attributable to | |||
| Comprehensive income for the period attributable to owners of parent | 418.16 | 1324.95 | ||
| Total comprehensive income for the period attributable to owners of parent non-controlling interests | 0.06 | 0.27 | ||
| 21 | Details of equity share capital | |||
| Paid-up equity share capital | 568.52 | 568.52 | ||
| Face value of equity share capital | 10 | 10 | ||
| 22 | Reserves excluding revaluation reserve | 5077.4 | ||
| 23 | Earnings per share | |||
| i | Earnings per equity share for continuing operations | |||
| Basic earnings (loss) per share from continuing operations | 7.33 | 22.96 | ||
| Diluted earnings (loss) per share from continuing operations | 7.33 | 22.96 | ||
| ii | Earnings per equity share for discontinued operations | |||
| Basic earnings (loss) per share from discontinued operations | 0 | 0 | ||
| Diluted earnings (loss) per share from discontinued operations | 0 | 0 | ||
| iii | Earnings per equity share (for continuing and discontinued operations) | |||
| Basic earnings (loss) per share from continuing and discontinued operations | 7.33 | 22.96 | ||
| Diluted earnings (loss) per share from continuing and discontinued operations | 7.33 | 22.96 | ||
| 24 | Debt equity ratio | Textual Information( 1) | ||
| 25 | Debt service coverage ratio | Textual Information( 2) | ||
| 26 | Interest service coverage ratio | Textual Information( 3) | ||
| 27 | Disclosure of notes on financial results | Textual Information(4) | ||
Statement of Asset and Liabilities | |||
| Particulars | Year ended (dd-mm-yyyy) | ||
| Date of start of reporting period | 01-04-2025 | ||
| Date of end of reporting period | 31-03-2026 | ||
| Whether results are audited or unaudited | Audited | ||
| Nature of report standalone or consolidated | Consolidated | ||
| Assets | |||
| 1 | Non-current assets | ||
| Property, plant and equipment | 3513.24 | ||
| Capital work-in-progress | 2.46 | ||
| Investment property | |||
| Goodwill | 0 | ||
| Other intangible assets | 243.1 | ||
| Intangible assets under development | |||
| Biological assets other than bearer plants | |||
| Investments accounted for using equity method | |||
| Non-current financial assets | |||
| Non-current investments | 0 | ||
| Trade receivables, non-current | |||
| Loans, non-current | 0 | ||
| Other non-current financial assets | |||
| 1 | Security Deposit | 42.26 | |
| 2 | Deposits with bank | 0.07 | |
| 3 | |||
| 4 | |||
| 5 | |||
| Details of other non-current financial assets | |||
| Total of other non-current financial assets | 42.33 | ||
| Total non-current financial assets | 42.33 | ||
| Deferred tax assets (net) | 42.96 | ||
| Other non-current assets | |||
| 1 | Non-current tax assets | 328.99 | |
| 2 | Balance with Government Authorities (other than income taxes) | 1.42 | |
| 3 | Prepaid Expenses | 2.22 | |
| 4 | Capital Advances | 0.94 | |
| 5 | |||
| Details of other non-current assets | |||
| Total of other non-current assets | 333.57 | ||
| Total non-current assets | 4177.66 | ||
| 2 | Current assets | ||
| Inventories | 3174.14 | ||
| Current financial asset | |||
| Current investments | 0 | ||
| Trade receivables, current | 3749.32 | ||
| Cash and cash equivalents | 904.09 | ||
| Bank balance other than cash and cash equivalents | 0 | ||
| Loans, current | 0 | ||
| Other current financial assets | |||
| 1 | Security Deposit | 8.1 | |
| 2 | Interest accrued on deposits | 1.89 | |
| 3 | Derivatives - Foreign-exchange forward contract | 11.53 | |
| 4 | |||
| 5 | |||
| Details of other current financial assets | |||
| Total of Other current financial assets | 21.52 | ||
| Total current financial assets | 4674.93 | ||
| Current tax assets (net) | 0 | ||
| Other current assets | |||
| 1 | Balance with Government Authorities (other than income taxes) | 561.51 | |
| 2 | Advances to suppliers | 79.98 | |
| 3 | Advances to employees | 0.15 | |
| 4 | Prepaid Expenses | 19.92 | |
| 5 | |||
| Details of other current assets | |||
| Total of other current assets | 661.56 | ||
| Total current assets | 8510.63 | ||
| 3 | Non-current assets classified as held for sale | ||
| 4 | Regulatory deferral account debit balances and related deferred tax Assets | ||
| Total assets | 12688.29 | ||
| Equity and liabilities | |||
| 1 | Equity | ||
| Equity attributable to owners of parent | |||
| Equity share capital | 568.52 | ||
| Other equity | 5077.4 | ||
| Total equity attributable to owners of parent | 5645.92 | ||
| Non controlling interest | 1.34 | ||
| Total equity | 5647.26 | ||
| 2 | Liabilities | ||
| Non-current liabilities | |||
| Non-current financial liabilities | |||
| Borrowings, non-current | 1076.25 | ||
| Trade Payables, non-current | |||
| (A) Total outstanding dues of micro enterprises and small enterprises | |||
| (B) Total outstanding dues of creditors other than micro enterprises and small enterprises | |||
| Total Trade payable | |||
| Other non-current financial liabilities | |||
| 1 | Lease liabilities | 128.22 | |
| 2 | |||
| 3 | |||
| 4 | |||
| 5 | |||
| Details of other non-current financial liabilities | |||
| Total of other non-current financial liabilities | 128.22 | ||
| Total non-current financial liabilities | 1204.47 | ||
| Provisions, non-current | 598.57 | ||
| Deferred tax liabilities (net) | |||
| Deferred government grants, Non-current | |||
| Other non-current liabilities | |||
| 1 | |||
| 2 | |||
| 3 | |||
| 4 | |||
| 5 | |||
| Details of other non-current liabilities | |||
| Total of other non-current liabilities | |||
| Total non-current liabilities | 1803.04 | ||
| Current liabilities | |||
| Current financial liabilities | |||
| Borrowings, current | 338.65 | ||
| Trade Payables, current | |||
| (A) Total outstanding dues of micro enterprises and small enterprises | 576.71 | ||
| (B) Total outstanding dues of creditors other than micro enterprises and small enterprises | 3623.36 | ||
| Total Trade payable | 4200.07 | ||
| Other current financial liabilities | |||
| 1 | Creditors for capital supplies | 116.08 | |
| 2 | Dividend payable | 0.07 | |
| 3 | Lease liabilities | 6.12 | |
| 4 | |||
| 5 | |||
| Details of other current financial liabilities | |||
| Total of other current financial liabilities | 122.27 | ||
| Total current financial liabilities | 4660.99 | ||
| Other current liabilities | |||
| 1 | Advance from customers | 51.23 | |
| 2 | Statutory remittances | 156.59 | |
| 3 | |||
| 4 | |||
| 5 | |||
| Details of other current liabilities | |||
| Total of other current liabilities | 207.82 | ||
| Provisions, current | 369.18 | ||
| Current tax liabilities (Net) | |||
| Deferred government grants, Current | |||
| Total current liabilities | 5237.99 | ||
| 3 | Liabilities directly associated with assets in disposal group classified as held for sale | ||
| 4 | Regulatory deferral account credit balances and related deferred tax liability | ||
| Total liabilities | 7041.03 | ||
| Total equity and liabilities | 12688.29 | ||
| Disclosure of notes on assets and liabilities | |||
Other Comprehensive Income | |||
| Date of start of reporting period | 01-01-2026 | 01-04-2025 | |
| Date of end of reporting period | 31-03-2026 | 31-03-2026 | |
| Whether results are audited or unaudited | Unaudited | Audited | |
| Nature of report standalone or consolidated | Consolidated | Consolidated | |
| Other comprehensive income [Abstract] | |||
| 1 | Amount of items that will not be reclassified to profit and loss | ||
| 1 | Remeasurement of net defined benefit liability | 1.74 | 25.91 |
| Total Amount of items that will not be reclassified to profit and loss | 1.74 | 25.91 | |
| 2 | Income tax relating to items that will not be reclassified to profit or loss | 0.43 | 6.52 |
| 3 | Amount of items that will be reclassified to profit and loss | ||
| Total Amount of items that will be reclassified to profit and loss | |||
| 4 | Income tax relating to items that will be reclassified to profit or loss | ||
| 5 | Total Other comprehensive income | 1.31 | 19.39 |
Cash flow statement, indirect | ||||||
| Particulars | Year ended (dd-mm-yyyy) | |||||
| Date of start of reporting period | 01-04-2025 | |||||
| Date of end of reporting period | 31-03-2026 | |||||
| Whether results are audited or unaudited | Audited | |||||
| Nature of report standalone or consolidated | Consolidated | |||||
| Part I | Blue color marked fields are non-mandatory. | |||||
| 1 | Statement of cash flows | |||||
| Cash flows from used in operating activities | ||||||
| Profit before tax | 1727.78 | |||||
| 2 | Adjustments for reconcile profit (loss) | |||||
| Adjustments for finance costs | 189.46 | |||||
| Adjustments for decrease (increase) in inventories | -186.9 | |||||
| Adjustments for decrease (increase) in trade receivables, current | -836.28 | |||||
| Adjustments for decrease (increase) in trade receivables, non-current | 0 | |||||
| Adjustments for decrease (increase) in other current assets | -395.16 | |||||
| Adjustments for decrease (increase) in other non-current assets | 1.97 | |||||
| Adjustments for other financial assets, non-current | 0.42 | |||||
| Adjustments for other financial assets, current | -1.88 | |||||
| Adjustments for other bank balances | 0 | |||||
| Adjustments for increase (decrease) in trade payables, current | 761.36 | |||||
| Adjustments for increase (decrease) in trade payables, non-current | 0 | |||||
| Adjustments for increase (decrease) in other current liabilities | 18.88 | |||||
| Adjustments for increase (decrease) in other non-current liabilities | 0 | |||||
| Adjustments for depreciation and amortisation expense | 457 | |||||
| Adjustments for impairment loss reversal of impairment loss recognised in profit or loss | 0 | |||||
| Adjustments for provisions, current | 34.12 | |||||
| Adjustments for provisions, non-current | 106.49 | |||||
| Adjustments for other financial liabilities, current | 0 | |||||
| Adjustments for other financial liabilities, non-current | 0 | |||||
| Adjustments for unrealised foreign exchange losses gains | 26.37 | |||||
| Adjustments for dividend income | 0 | |||||
| Adjustments for interest income | 2.89 | |||||
| Adjustments for share-based payments | 0 | |||||
| Adjustments for fair value losses (gains) | -1.47 | |||||
| Adjustments for undistributed profits of associates | 0 | |||||
| Other adjustments for which cash effects are investing or financing cash flow | -12.28 | |||||
| Other adjustments to reconcile profit (loss) | 0 | |||||
| Other adjustments for non-cash items | -73.06 | |||||
| Share of profit and loss from partnership firm or association of persons or limited liability partnerships | 0 | |||||
| Total adjustments for reconcile profit (loss) | 86.15 | |||||
| Net cash flows from (used in) operations | 1813.93 | |||||
| Dividends received | 0 | |||||
| Interest paid | 0 | |||||
| Interest received | 0 | |||||
| Income taxes paid (refund) | 468.34 | |||||
| Other inflows (outflows) of cash | 0 | |||||
| Net cash flows from (used in) operating activities | 1345.59 | |||||
| 3 | Cash flows from used in investing activities | |||||
| Cash flows from losing control of subsidiaries or other businesses | 0 | |||||
| Cash flows used in obtaining control of subsidiaries or other businesses | 0 | |||||
| Other cash receipts from sales of equity or debt instruments of other entities | 0 | |||||
| Other cash payments to acquire equity or debt instruments of other entities | 0 | |||||
| Other cash receipts from sales of interests in joint ventures | 0 | |||||
| Other cash payments to acquire interests in joint ventures | 0 | |||||
| Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships | 0 | |||||
| Cash payment for investment in partnership firm or association of persons or limited liability partnerships | 0 | |||||
| Proceeds from sales of property, plant and equipment | 1.47 | |||||
| Purchase of property, plant and equipment | 320.83 | |||||
| Proceeds from sales of investment property | 0 | |||||
| Purchase of investment property | 0 | |||||
| Proceeds from sales of intangible assets | 0 | |||||
| Purchase of intangible assets | 1.5 | |||||
| Proceeds from sales of intangible assets under development | 0 | |||||
| Purchase of intangible assets under development | 0 | |||||
| Proceeds from sales of goodwill | 0 | |||||
| Purchase of goodwill | 0 | |||||
| Proceeds from biological assets other than bearer plants | 0 | |||||
| Purchase of biological assets other than bearer plants | 0 | |||||
| Proceeds from government grants | 0 | |||||
| Proceeds from sales of other long-term assets | 0 | |||||
| Purchase of other long-term assets | 0 | |||||
| Cash advances and loans made to other parties | 0 | |||||
| Cash receipts from repayment of advances and loans made to other parties | 0 | |||||
| Cash payments for future contracts, forward contracts, option contracts and swap contracts | 0 | |||||
| Cash receipts from future contracts, forward contracts, option contracts and swap contracts | 0 | |||||
| Dividends received | 0 | |||||
| Interest received | 2.47 | |||||
| Income taxes paid (refund) | 0 | |||||
| Other inflows (outflows) of cash | 14.14 | |||||
| Net cash flows from (used in) investing activities | -304.25 | |||||
| 4 | Cash flows from used in financing activities | |||||
| Proceeds from changes in ownership interests in subsidiaries | 0 | |||||
| Payments from changes in ownership interests in subsidiaries | 0 | |||||
| Proceeds from issuing shares | 0 | |||||
| Proceeds from issuing other equity instruments | 0 | |||||
| Payments to acquire or redeem entity's shares | 0 | |||||
| Payments of other equity instruments | 0 | |||||
| Proceeds from exercise of stock options | 0 | |||||
| Proceeds from issuing debentures notes bonds etc | 0 | |||||
| Proceeds from borrowings | 12.6 | |||||
| Repayments of borrowings | 435.35 | |||||
| Payments of lease liabilities | 32.2 | |||||
| Dividends paid | 258.6 | |||||
| Interest paid | 175.64 | |||||
| Income taxes paid (refund) | 0 | |||||
| Other inflows (outflows) of cash | 0 | |||||
| Net cash flows from (used in) financing activities | -889.19 | |||||
| Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes | 152.15 | |||||
| 5 | Effect of exchange rate changes on cash and cash equivalents | |||||
| Effect of exchange rate changes on cash and cash equivalents | 68.9 | |||||
| Net increase (decrease) in cash and cash equivalents | 221.05 | |||||
| Cash and cash equivalents cash flow statement at beginning of period | 683.04 | |||||
| Cash and cash equivalents cash flow statement at end of period | 904.09 | |||||
Details of Impact of Audit Qualification | |||||
| Whether results are audited or unaudited | Audited | ||||
| Declaration of unmodified opinion or statement on impact of audit qualification | Declaration of unmodified opinion | ||||
| Auditor's opinion | |||||
| Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015: The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified opinion for the period on Consolidated results | Yes | ||||
| Audit firm's name | Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI | Certificate valid upto | |||
| 1 | M/S Deloitte Haskins & Sells LLP | Yes | 31-07-2027 | ||